Simplify VettaFi Private Credit Strategy ETF (PCR) Performance
PCR total return
Distributions reinvested · as of Oct 23, 2026- YTD
- −15.3% since Dec 31, 2025
- 1 year
- −18.0% total return
- Since first price
- −20.1% since 2025
PCR trailing returns vs SPY, QQQ, AGG
| Period | PCR total return | Price only | S&P 500 (SPY) | Nasdaq-100 (QQQ) | U.S. bonds (AGG) |
|---|---|---|---|---|---|
| 1 month | −1.7% | −2.6% | −1.0% | −5.0% | +0.9% |
| 3 months | −2.5% | −5.3% | +3.2% | +1.9% | −0.4% |
| 6 months | −7.6% | −12.9% | +7.8% | +8.4% | −1.5% |
| YTD | −15.3% | −22.5% | +12.3% | +15.1% | −1.0% |
| 1 year | −18.0% | −26.6% | +14.4% | +15.9% | −1.1% |
| Since inceptionSep 23, 2025 | −20.1% | −28.6% | — | — | — |
Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.
Growth of $10,000: PCR vs SPY
From Sep 23, 2025: PCR grew to $7,985, SPY to $11,583.
Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.
PCR returns by calendar year
2026 is year to date.
PCR annual returns table
| Year | PCR | Largest drop | SPY | QQQ | AGG |
|---|---|---|---|---|---|
| 2026YTD | −15.3% | −18.8% | +12.3% | +15.1% | −1.0% |
Largest drop = deepest fall from a high within that calendar year.
Calendar-year return vs largest drop within the year
Most years include a sizable fall at some point even when the year ends higher.
PCR largest drawdowns
Now 20.1% below the high| Peak | Decline | Bottom | Recovered | Fall | Underwater |
|---|---|---|---|---|---|
| Sep 23, 2025 | −21.5% | Oct 14, 2026 | not yet | 1.1 years | 1.1 years so far |
Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.
PCR risk statistics
| Statistic | Since 2025 |
|---|---|
| Annualized return | −18.3% |
| Volatility (annualized) | 17.1% |
| Sharpe ratio | -1.30 |
| Sortino ratio | -1.47 |
| Best month | +7.4% |
| Worst month | −10.9% |
| Best 12 months | −18.3% |
| Worst 12 months | −18.3% |
| Positive months | 25% |
| Beta vs S&P 500 | — |
| Correlation with S&P 500 | — |
From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.
PCR rolling returns
| Holding period | Periods | Worst | Median | Best | Positive |
|---|---|---|---|---|---|
| 1-year | 2 | −18.3% | −18.0% | −17.7% | 0% |
Every holding period starting at a month-end since 2025. Returns for 3 years and longer are annualized.
PCR performance overview
Simplify VettaFi Private Credit Strategy ETF (PCR) returned −18.0% over the past year, with distributions reinvested. Since its first recorded price on Sep 23, 2025 it has returned −20.1%. Over the same year S&P 500 (SPY) returned +14.4%.
The deepest decline was −21.5%, from Sep 23, 2025 to Oct 14, 2026; the fund has not yet regained that high. Volatility has been 17.1% a year.
Related: PCR chart, PCR dividends. See the PCR overview for the latest quote and fund facts.
PCR performance FAQ
What is the PCR return over the past year?
PCR returned −18.0% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it fell 26.6%.
How much would $10,000 invested in PCR be worth?
$10,000 invested in PCR at its first recorded close on September 23, 2025 would be worth about $7,985 on October 23, 2026 with distributions reinvested.
What is the biggest drawdown of PCR?
The largest peak-to-trough decline was −21.5% between September 23, 2025 and October 14, 2026. It has not yet recovered to that high; it is 20.1% below its peak.
How volatile is PCR?
Over the past history PCR had an annualized volatility of 17.1% and a Sharpe ratio of -1.30 (excess return over 1–3 month T-bills per unit of risk).